格隆汇6月27日丨复星医药(600196.SH)公布,为吸引、激励及挽留技术熟练、经验丰富的合资格人士为复宏汉霖集团的长期发展目标奋斗,认可及肯定合资格人士对复宏汉霖集团现有或潜在的贡献、鼓励其致力提升复宏汉霖集团及复宏汉霖股份之价值,并为复宏汉霖集团提供灵活机制以留任、激励、奖励、酬谢、补偿合资格人士等,本公司控股子公司复宏汉霖拟分别采纳(1)购股权计划、及(2)受限制股份单位计划。购股权计划...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.